Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Citius Pharmaceuticals Inc (CTXR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014161
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc, is a specialty pharmaceutical company that focused on the development and commercialization of adjunctive cancer care and critical care drug products. The company‘s proprietary product candidates include mino-lok, an antibiotic lock solution used for the treatment of patients with catheter-related bloodstream infections; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine intended for the treatment of persons suffering from mild to moderate hemorrhoids. Citius is headquartered in Cranford, New Jersey, the US.

Citius Pharmaceuticals Inc (CTXR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Leonard-Meron Biosciences Raises USD0.6 Million in Venture Financing 10
Licensing Agreements 11
Leonard Meron Biosciences Expands Licensing Agreement with Novel Anti-Infective Therapeutics 11
Equity Offering 12
Citius Pharma Plans to Raise up to USD50 Million in Public Offering of Shares and Warrants 12
Citius Pharma Raises USD6.8 Million in Public Offering of Shares and Warrants 13
Citius Pharma Raises USD0.8 Million in Third Tranche of Private Placement of Units 15
Citius Pharma Raises USD0.2 Million in Seconds Tranche of Private Placement of Units 16
Citius Pharma Plans to Raise Funds in Public Offering of Shares 17
Citius Pharma Raises USD0.4 Million in Private Placement of Units 18
Citius Pharma Raises USD4.6 Million in Private Placement of Units 19
Citius Pharma Raises USD3 Million in Private Placement of Shares 20
Citius Pharma Raises USD1.5 Million in Private Placement of Units 21
Citius Pharma Raises USD0.1 Million in Private Placement of Units 22
Citius Pharma Raises USD2.04 Million in Private Placement of Shares 23
Acquisition 24
Citius Pharma Acquires Leonard Meron Biosciences 24
Trail One Acquires Citius Pharma in Reverse Takeover Transaction 25
Citius Pharmaceuticals Inc – Key Competitors 26
Citius Pharmaceuticals Inc – Key Employees 27
Citius Pharmaceuticals Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Jun 28, 2016: Citius Pharmaceuticals Announces Appointment of Dr. Eugene Holuka to Its Board of Directors 29
Clinical Trials 30
Feb 01, 2016: Citius Pharmaceuticals Announces Results from Phase 2a Trial of Hydrocortisone and Lidocaine Combination Cream in Patients with Grade I and II Hemorrhoids 30
Other Significant Developments 31
Oct 11, 2017: Citius Pharmaceuticals Issues Shareholder Letter 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Citius Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Citius Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Leonard-Meron Biosciences Raises USD0.6 Million in Venture Financing 10
Leonard Meron Biosciences Expands Licensing Agreement with Novel Anti-Infective Therapeutics 11
Citius Pharma Plans to Raise up to USD50 Million in Public Offering of Shares and Warrants 12
Citius Pharma Raises USD6.8 Million in Public Offering of Shares and Warrants 13
Citius Pharma Raises USD0.8 Million in Third Tranche of Private Placement of Units 15
Citius Pharma Raises USD0.2 Million in Seconds Tranche of Private Placement of Units 16
Citius Pharma Plans to Raise Funds in Public Offering of Shares 17
Citius Pharma Raises USD0.4 Million in Private Placement of Units 18
Citius Pharma Raises USD4.6 Million in Private Placement of Units 19
Citius Pharma Raises USD3 Million in Private Placement of Shares 20
Citius Pharma Raises USD1.5 Million in Private Placement of Units 21
Citius Pharma Raises USD0.1 Million in Private Placement of Units 22
Citius Pharma Raises USD2.04 Million in Private Placement of Shares 23
Citius Pharma Acquires Leonard Meron Biosciences 24
Trail One Acquires Citius Pharma in Reverse Takeover Transaction 25
Citius Pharmaceuticals Inc, Key Competitors 26
Citius Pharmaceuticals Inc, Key Employees 27
Citius Pharmaceuticals Inc, Subsidiaries 28

★海外企業調査レポート[Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Modern Times Group MTG AB:企業の戦略・SWOT・財務情報
    Modern Times Group MTG AB - Strategy, SWOT and Corporate Finance Report Summary Modern Times Group MTG AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • LifeScan Inc-医療機器分野:企業M&A・提携分析
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Mitsubishi Electric Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • International Business Machines Corporation:企業の戦略・SWOT・財務情報
    International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report Summary International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Bajaj Allianz Life Insurance Company Ltd:企業の戦略・SWOT・財務情報
    Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Jiangsu Kanion Pharmaceutical Co Ltd (600557):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Kanion Pharmaceutical Co Ltd (Jiangsu Kanion) is a developer, producer and marketer of concentrated drugs. The company offers products in the therapeutic areas of orthopedics, cardiovascular, gynecology, antitumor, anti-infective, and others. It also offers products for fever, headac …
  • Hermes International SA:企業の戦略・SWOT・財務分析
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Entertainment One Ltd.:企業の戦略・SWOT・財務分析
    Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report Summary Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Liquid Media Group Ltd:企業の戦略・SWOT・財務分析
    Liquid Media Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Liquid Media Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PT ANTAM (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • H-E-B Grocery Company L.P.:企業の戦略・SWOT・財務情報
    H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report Summary H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • JFE Holdings, Inc. (5411):企業の財務・戦略的SWOT分析
    JFE Holdings, Inc. (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • STRABAG International GmbH:企業の戦略的SWOT分析
    STRABAG International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ED&F Man Holdings Ltd:企業の戦略的SWOT分析
    ED&F Man Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sectra AB (SECT B):企業の財務・戦略的SWOT分析
    Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Renishaw Plc (RSW):企業の財務・戦略的SWOT分析
    Summary Renishaw Plc (Renishaw) is a medical device company that designs, manufactures and markets measurement, motion control, spectroscopy and precision machining products. The company offers precision measurement and process control, position and motion control, 3D laser scanning and measurement, …
  • ResCare Inc:企業の戦略的SWOT分析
    ResCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Alarko Holding AS (ALARK):企業の財務・戦略的SWOT分析
    Alarko Holding AS (ALARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆